BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8219659)

  • 1. Effects of angiotensin-converting enzyme inhibition on renal sodium handling after furosemide injection.
    Nowack R; Fliser D; Richter J; Horne C; Mutschler E; Ritz E
    Clin Investig; 1993 Aug; 71(8):622-7. PubMed ID: 8219659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
    Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J
    J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of cilazapril alone and in combination with frusemide in healthy subjects.
    Johnston GD; Passmore AP
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):235S-242S. PubMed ID: 2527536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
    Uusitupa M; Korhonen M; Litmanen H; Niskanen L; Väisänen S; Rauramaa R
    J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of ACE inhibitors and vasodilators on renal function curve in patients with primary hypertension.
    Fliser D; Nowack R; Wolf G; Ritz E
    Blood Press; 1993 Dec; 2(4):296-300. PubMed ID: 8173699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
    Reed S; Greene P; Ryan T; Cerimele B; Schwertschlag U; Weinberger M; Voelker J
    Br J Clin Pharmacol; 1995 Jan; 39(1):51-7. PubMed ID: 7756099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the pharmacokinetics and pharmacodynamics of cilazapril between Chinese and Caucasian healthy, normotensive volunteers.
    Anderson PJ; Critchley JA; Tomlinson B
    Eur J Clin Pharmacol; 1996; 50(1-2):57-62. PubMed ID: 8739812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
    Vervoort G; Hertenberg F; Wetzels JF; Smits P
    J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive and renal effects of cilazapril and their reversal by angiotensin in renovascular hypertensive rats.
    Ding YA; Chang ST; Shieh SM; Huang WC
    Clin Sci (Lond); 1988 Apr; 74(4):365-72. PubMed ID: 2965632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dietary salt and angiotensin-converting enzyme inhibitor on ATP-driven Ca pump and Na/Ca exchange in aortic rings of Dahl rats.
    Ashida T; Yoshimi H; Kawano Y; Matsuoka H; Omae T
    Clin Exp Hypertens; 1996 Aug; 18(6):851-71. PubMed ID: 8842567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin converting enzyme inhibition on renal response to atrial natriuretic factor in rats.
    Wu JN; Huang WC
    Proc Natl Sci Counc Repub China B; 1988 Jul; 12(3):186-93. PubMed ID: 2977443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal effects of angiotensin II in normotensive subjects on short-term cilazapril treatment.
    Hannedouche T; Ikeni A; Marques LP; Natov S; Dechaux M; Schmitt F; Lacour B; Grünfeld JP
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S25-7. PubMed ID: 1382161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
    Bernasconi M; Marone C; Beretta-Piccoli C; Lepori G; Shaw S; Weidmann P
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):348-55. PubMed ID: 1829371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
    Bak M; Shalmi M; Petersen JS; Poulsen LB; Christensen S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):33-40. PubMed ID: 8392557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension.
    Schlaich MP; Klingbeil AU; Jacobi J; Delles C; Schneider MP; Schmidt BM; Schmieder RE
    J Hypertens; 2002 Jan; 20(1):117-24. PubMed ID: 11791034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
    Burnier M; Rutschmann B; Nussberger J; Versaggi J; Shahinfar S; Waeber B; Brunner HR
    Hypertension; 1993 Sep; 22(3):339-47. PubMed ID: 8349327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the actions of cilazapril in normal, dietary sodium-depleted and two-kidney, one clip Goldblatt hypertensive anaesthetised rats.
    al-Qattan KK; Johns EJ
    J Hypertens; 1992 May; 10(5):423-9. PubMed ID: 1317902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers.
    Fasanella d'Amore T; Bussien JP; Nussberger J; Waeber B; Turini GA; Brunner HR; Kler L; Francis RJ
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):26-31. PubMed ID: 2434790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.